Delivery Order SPE2DR25D3012-SPE2DR26F4E1X
Award Date 12/30/25
Potential Completion Date 1/22/26
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ibrance 75 mg tablets (quantity 7) with a ceiling value of $8,123.96 and firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of October 16, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,561.41 for Ibrance 75 mg tablets (7-count units) on December 11, 2025, with completion scheduled for January 5, 2026. This firm fixed-price delivery order represents a non-compete award to the pharmaceutical distributor for supply to federal medical procurement needs. The place of performance is listed as AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ibrance 100 mg tablets in 7-count packaging, with a contract ceiling value of $24,367.44 and completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ibrance 75 mg tablets (7-count packages) with a ceiling value of $8,123.96. This is a firm fixed-price delivery order with no set-aside designation, issued as part of a competitive award process. The order is scheduled for ultimate completion by October 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ibrance 125 mg tablets (quantity 7). This firm fixed-price delivery order, valued at $8,555.21, is scheduled for completion by December 24, 2025, with performance to be conducted at the company's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation through competitive procurement, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ibrance 75 mg tablets (7-count packaging) with a ceiling value of $8,561.41. This firm fixed-price delivery order, with an ultimate completion date of November 24, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Ibrance 75 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $42,807.05 and an ultimate completion date of January 22, 2026. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg tablets in a quantity of seven units, with a ceiling value of $17,122.82. This contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-unit packaging). This firm fixed-price contract, awarded on November 28, 2025, with an ultimate completion date of December 19, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,559.84. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 21, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...